Home Your basket
• Influence of Platelet Ric...
   Price 10.50 €
• The relevance of Choukrou...
   Price 10.50 €
• Vision preference in dyna...
   Price 10.50 €
• Myasthenia gravis and oro...
   Price 5.50 €
• Aesthetic profiloplasty: ...
   Price 10.50 €
• Adolescence and cochlear ...
   Price 10.50 €
• The length of the piston ...
   Price 10.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Cervical cystic lymphangi...
   Price 5.50 €
• Type 1 tympanoplasties in...
   Price 12.00 €
• Social consequence of a d...
   Price 10.50 €
• These lesions of the voca...
   Price 10.50 €
• Mucormycosis – early diag...
   Price 10.50 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Neuroplasticity in the au...
   Price 10.50 €
• Results of six years expe...
   Price 8.50 €
• Role of [18]-FDG PET/CT i...
   Price 10.50 €
• Zenker’s diverticulum in ...
   Price 8.50 €
• Primary nasal tuberculosi...
   Price 5.50 €
• Middle ear osteoma: A rar...
   Price 8.50 €
• A survey of current wound...
   Price 5.50 €
• Invasive cholesteatoma in...
   Price 10.50 €
• Inferior turbinate hypert...
   Price 10.50 €
• Nasal involvement in Croh...
   Price 10.50 €
• Objective tinnitus and es...
   Price 5.50 €
• Context influence on the ...
   Price 10.50 €
• The sound intensity after...
   Price 10.50 €
• Role and importance of pH...
   Price 12.00 €
• Bilateral facial nerve sc...
   Price 10.50 €
• The silent sinus syndrome...
   Price 12.50 €
• Quality of life before an...
   Price 10.50 €
• Wegener granulomatosis mi...
   Price 14.00 €
• Study of tongue pressure ...
   Price 12.00 €
• Oculo-orbital complicatio...
   Price 14.00 €

Total Order 329.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

PAEDIATRICS

Universal hearing screening in the Champagne-Ardenne regions: Results and consideration after 55 000 births from January 2004 to June 2007


Authors : Langagne T, Schmidt P, Leveque M, Chays A. (Reims)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:153-158.

Article published in french
Downloadable PDF document french



Summary : Aim: This study presents the results of the Universal Newborn Hearing Screening (UNHS) experience in Champagne-Ardenne from January 2004 to June 2007. Materials and methods: A UNHS program was introduced in the entire French region of Champagne-Ardenne in January 2004. Developed upon a strong demand from public and private medical institutions, the program’s aim is the early detection and treatment of bilateral profound or severe hearing loss. The program is composed of 2 steps: the first test is realised in maternity and consists of automated OtoAcoustic Emissions (aOAE). When absent in both ears at first test (positive screening test), the child is referred to a second test 15 days after maternity discharge (aOAE or automated Auditory Brainstem Response (aABR)). If the second test is still failed (positive screening test), the child is referred to a diagnostic procedure (Auditory Brainstem Response) realised by a paediatrician ENT in a reference centre. The UNHS program differs for newborns in Neonatal Intensive Care Units where aABR is realised at first test because of the high frequency of auditory neuropathy in this population. All results are collected in the Regional Neonatal Screening Centre, in charge of the UNHS follow-up. Results: 53 930 newborns benefited from the UNHS program, which represent 98.7% of the 54 790 births in the region during this period. 591 newborns had a positive first test (no aOAE responses) and were referred to the second test. 532 had a negative second test and 46 had a positive second test. 22 children could not have the second test: 4 children deceased, 9 were lost to follow-up (the families moved outside the region) and 9 families refused the second test. The 46 neonates were referred to the diagnostic ABR test and 42 of those 46 babies were diagnosed with neonatal bilateral hearing losses before the age of 6 months. Conclusion: This UNHS experience demonstrates that such UNHS programs are feasible and reliable, at least in a region as wide as Champagne-Ardenne. It achieved to diagnose 42 hearing impaired children, who could benefit from an early intervention for their handicap.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE